TAKEDA PHARMACEUTICAL CO LTD quarter change: USA Stocks, Added
In share positions in stocks (listed in the US), from the quarter ended 2025-06-30 to 2025-09-30, TAKEDA PHARMACEUTICAL CO LTD opened 0 positions, added to 0, reduced 0, sold out of 1 and left 6 unchanged. The largest increase in value was OVID (+$7,306,215); the largest decrease was HLVX (-$13,381,160).
Two Form 13F-HR filings compared (SEC CIK 1395064): 2025-06-30 (filed 2025-08-08) and 2025-09-30 (filed 2025-11-13). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
No position of this class changed this way between the two filings.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||